Eradication of an outbreak of vancomycin-resistant Enterococcus (VRE): The cost of a failure in the systematic screening

Antimicrobial Resistance and Infection Control

Volumn 2, Issue 1, 2013, Pages

  Escaut, Lélia ^a   Bouam, Samir ^b   Frank Soltysiak, Marie ^a   Rudant, Eric ^b   Saliba, Faouzi ^b   Kassis, Najiby ^b   Presiozi, Paul ^c   Vittecoq, Daniel ^a  

^a BICÊTRE HOSPITAL   (France)

^b HÔPITAL PAUL BROUSSE   (France)

^c Department of public health Bicêtre Hospital ^*

Author keywords

Active surveillance; Cost; Outbreak; Vancomycin resistant Enterococcus

Indexed keywords

VANCOMYCIN;

ADULT; ARTICLE; BACTERIAL COLONIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE CONTROL; DISEASE SEVERITY; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; EPIDEMIC; FEMALE; HEALTH CARE COST; HEALTH CARE PLANNING; HOSPITAL COST; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; TREATMENT FAILURE; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 84899869222     PISSN: None     EISSN: 20472994     Source Type: Journal    
DOI: 10.1186/2047-2994-2-18     Document Type: Article

References (10)

1. Muto CA, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003, 24(5):362-386. 10.1086/502213, 12785411.
2. Salgado CD. The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients. Am J Infect Control 2008, 36(10):S175. e5-8.
3. Huskins WC, et al. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 2011, 364(15):1407-1418. 10.1056/NEJMoa1000373, 3410743, 21488763.
4. Werner G, et al. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 2008, 13(47):1-11.
5. Russell DL, et al. Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients. Am J Transplant 2008, 8(8):1737-1743. 10.1111/j.1600-6143.2008.02304.x, 18557723.
6. Sagel U, et al. Vancomycin-resistant enterococci outbreak, Germany, and calculation of outbreak start. Emerg Infect Dis 2008, 14(2):317-319. 10.3201/eid1402.070752, 2600185, 18258130.
7. Ridwan B, et al. What action should be taken to prevent spread of vancomycin resistant enterococci in European hospitals?. BMJ 2002, 324(7338):666-668. 10.1136/bmj.324.7338.666, 1122583, 11895829.
8. Pearman JW. 2004 Lowbury Lecture: the Western Australian experience with vancomycin-resistant enterococci - from disaster to ongoing control. J Hosp Infect 2006, 63(1):14-26. 10.1016/j.jhin.2005.10.017, 16563562.
9. Cooper BS, et al. Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ 2004, 329(7465):533. 10.1136/bmj.329.7465.533, 516101, 15345626.
10. Montecalvo MA, et al. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting. Infect Control Hosp Epidemiol 2001, 22(7):437-442. 10.1086/501931, 11583213.